The disconnect between our results may be due to the use of a different injury model; while both models cause increased afterload, Angiotensin II has additional pharmacologic effects on the heart that contribute to CF activation and production of Tgfb1 [42,43,44,45,46]. The gene discussed is AGT; the disease is cystic fibrosis.